Among 16 analysts covering Zimmer Biomet Holdings (NYSE:ZBH), 12 have Buy rating, 1 Sell and 3 Hold. Therefore 75% are positive. Zimmer Biomet Holdings had 28 analyst reports since August 27, 2015 according to SRatingsIntel. Needham maintained Zimmer Biomet Holdings Inc (NYSE:ZBH) on Friday, January 29 with “Buy” rating. The rating was maintained by Needham with “Strong Buy” on Thursday, January 26. UBS maintained the shares of ZBH in report on Tuesday, August 2 with “Neutral” rating. The rating was initiated by Guggenheim with “Neutral” on Thursday, June 9. The company was upgraded on Tuesday, November 1 by Needham. Barclays Capital maintained Zimmer Biomet Holdings Inc (NYSE:ZBH) rating on Tuesday, August 23. Barclays Capital has “Overweight” rating and $145 target. The rating was downgraded by UBS on Thursday, December 15 to “Sell”. The firm has “Buy” rating given on Thursday, March 17 by Nomura. The stock of Zimmer Biomet Holdings Inc (NYSE:ZBH) has “Outperform” rating given on Monday, November 2 by RBC Capital Markets. As per Wednesday, February 1, the company rating was maintained by RBC Capital Markets. See Zimmer Biomet Holdings Inc (NYSE:ZBH) latest ratings:
01/02/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $130.00 New Target: $133.00 Maintain
26/01/2017 Broker: Needham Rating: Strong Buy Old Target: $148.00 New Target: $151.00 Maintain
15/12/2016 Broker: UBS Old Rating: Neutral New Rating: Sell Downgrade
29/11/2016 Broker: Citigroup Old Rating: Sell New Rating: Neutral Upgrade
08/11/2016 Broker: Northcoast Old Rating: Buy New Rating: Neutral Downgrade
01/11/2016 Broker: Needham Old Rating: Buy New Rating: Strong Buy Upgrade
The stock of 500.com Ltd (NYSE:WBAI) is a huge mover today! About 115,652 shares traded. 500.com Ltd (NYSE:WBAI) has declined 24.62% since August 25, 2016 and is downtrending. It has underperformed by 33.38% the S&P500.The move comes after 9 months positive chart setup for the $6.05 billion company. It was reported on Apr, 3 by Barchart.com. We have $15.62 PT which if reached, will make NYSE:WBAI worth $423.50 million more.
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The company has market cap of $24.58 billion. The Company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. It has a 80.35 P/E ratio. The Firm manages its activities through three geographic operating divisions: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets.
About 121,982 shares traded. Zimmer Biomet Holdings Inc (NYSE:ZBH) has declined 4.72% since August 25, 2016 and is downtrending. It has underperformed by 13.48% the S&P500.
